Eric G. Carter's most recent trade in Adverum Biotechnologies Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 23, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Adverum Biotechnologies Inc | Eric G. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2020 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |